Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients

Ji, Jianguang LU orcid ; Sundquist, Jan LU and Sundquist, Kristina LU (2018) In Nature Communications 9(1).
Abstract

Recent evidence suggests that cholera toxin might have multiple functions regarding the ability to regulate the immune system. However, it is unknown whether subsequent administration of cholera vaccine might affect the mortality rate in patients with prostate cancer. Here we report that patients in Sweden, who were diagnosed with prostate cancer between July 2005 and December 2014 and used cholera vaccine, have a decreased risk of death from prostate cancer (HR, 0.57; 95% CI, 0.40-0.82) as compared to patients with prostate cancer but without cholera vaccine use, adjusted for a range of confounding factors. In addition, patients using cholera vaccine show a decreased risk of death overall (HR, 0.53; 95% CI, 0.41-0.69). The decreased... (More)

Recent evidence suggests that cholera toxin might have multiple functions regarding the ability to regulate the immune system. However, it is unknown whether subsequent administration of cholera vaccine might affect the mortality rate in patients with prostate cancer. Here we report that patients in Sweden, who were diagnosed with prostate cancer between July 2005 and December 2014 and used cholera vaccine, have a decreased risk of death from prostate cancer (HR, 0.57; 95% CI, 0.40-0.82) as compared to patients with prostate cancer but without cholera vaccine use, adjusted for a range of confounding factors. In addition, patients using cholera vaccine show a decreased risk of death overall (HR, 0.53; 95% CI, 0.41-0.69). The decreased mortality rate is largely consistent, irrespective of patients' age or tumor stage at diagnosis. In this population-based study, we suggest that subsequent administration of cholera vaccine after prostate cancer diagnosis might reduce the mortality rate.

(Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Nature Communications
volume
9
issue
1
article number
2367
publisher
Nature Publishing Group
external identifiers
  • pmid:29915319
  • scopus:85048757513
ISSN
2041-1723
DOI
10.1038/s41467-018-04814-4
language
English
LU publication?
yes
id
b99835b4-58c1-42b8-9208-b2e379b4700a
date added to LUP
2018-07-04 08:27:05
date last changed
2024-04-01 07:49:25
@article{b99835b4-58c1-42b8-9208-b2e379b4700a,
  abstract     = {{<p>Recent evidence suggests that cholera toxin might have multiple functions regarding the ability to regulate the immune system. However, it is unknown whether subsequent administration of cholera vaccine might affect the mortality rate in patients with prostate cancer. Here we report that patients in Sweden, who were diagnosed with prostate cancer between July 2005 and December 2014 and used cholera vaccine, have a decreased risk of death from prostate cancer (HR, 0.57; 95% CI, 0.40-0.82) as compared to patients with prostate cancer but without cholera vaccine use, adjusted for a range of confounding factors. In addition, patients using cholera vaccine show a decreased risk of death overall (HR, 0.53; 95% CI, 0.41-0.69). The decreased mortality rate is largely consistent, irrespective of patients' age or tumor stage at diagnosis. In this population-based study, we suggest that subsequent administration of cholera vaccine after prostate cancer diagnosis might reduce the mortality rate.</p>}},
  author       = {{Ji, Jianguang and Sundquist, Jan and Sundquist, Kristina}},
  issn         = {{2041-1723}},
  language     = {{eng}},
  month        = {{12}},
  number       = {{1}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Nature Communications}},
  title        = {{Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients}},
  url          = {{http://dx.doi.org/10.1038/s41467-018-04814-4}},
  doi          = {{10.1038/s41467-018-04814-4}},
  volume       = {{9}},
  year         = {{2018}},
}